These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 13861108)

  • 1. Effects of LSD-25 on relatives of schizophrenic patients.
    ANASTASOPOULOS G; PHOTIADES H
    J Ment Sci; 1962 Jan; 108():95-8. PubMed ID: 13861108
    [No Abstract]   [Full Text] [Related]  

  • 2. 'Schizophrenia' produced by LSD-25.
    BOLTON WB
    Nurs Times; 1962 Jan; 58():22-4. PubMed ID: 13870860
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies in the effect of lysergic acid diethylamide (LSD-25): self- and object-size perception in schizophrenics and normal adults.
    LIEBERT RS; WERNER H; WAPNER S
    AMA Arch Neurol Psychiatry; 1958 May; 79(5):580-4. PubMed ID: 13519960
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of lysergic acid diethylamide, and differences between normals and schizophrenics on the Stroop Color-Word Test.
    WAPNER S; KRUS DM
    J Neuropsychiatr; 1960; 2():76-81. PubMed ID: 13783079
    [No Abstract]   [Full Text] [Related]  

  • 5. Human figure drawings of schizophrenic and normal adults. Changes following administration of lysergic acid.
    MACHOVER K; LIEBERT R
    Arch Gen Psychiatry; 1960 Aug; 3():139-52. PubMed ID: 14419430
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of phencyclidine hydrochloride (Sernyl) with other drugs. Simulation of schizophrenic performance with phencyclidine hydrochloride (Sernyl), lysergic acid diethylamide (LSD-25), and amobarbital (Amytal) sodium; II. Symbolic and sequential thinking.
    COHEN BD; ROSENBAUM G; LUBY ED; GOTTLIEB JS
    Arch Gen Psychiatry; 1962 May; 6():395-401. PubMed ID: 13880223
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies in the effects of lysergic acid diethylamide (LSD-25); visual perception of verticality in schizophrenic and normal adults.
    LIEBERT RS; WAPNER S; WERNER H
    AMA Arch Neurol Psychiatry; 1957 Feb; 77(2):193-201. PubMed ID: 13393877
    [No Abstract]   [Full Text] [Related]  

  • 8. [LSD studies in electroshock-treated schizophrenic patients].
    IRANYI J
    Ideggyogy Sz; 1960 Mar; 13():65-73. PubMed ID: 13852980
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of LSD-25, serotonin and sera from schizophrenic patients on adult mammalian brain cultures.
    GEIGER RS
    J Neuropsychiatr; 1960 Apr; 1():185-99. PubMed ID: 13827117
    [No Abstract]   [Full Text] [Related]  

  • 10. Cross tolerance between D-2-brom-lysergic acid diethylamide (BOL-148) and the D-diethylamide of lysergic acid (LSD-25).
    ISBELL H; MINER EJ; LOGAN CR
    Psychopharmacologia; 1959 Nov; 1():109-16. PubMed ID: 14405871
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of sernyl with other drugs: simulation of schizophrenic performance with sernyl, LSD-25, and amobarbital (amytal) sodium; I. Attention, motor function, and proprioception.
    ROSENBAUM G; COHEN BD; LUBY ED; GOTTLIEB JS; YELEN D
    AMA Arch Gen Psychiatry; 1959 Dec; 1():651-6. PubMed ID: 14438905
    [No Abstract]   [Full Text] [Related]  

  • 12. Lysergic acid diethylamide (LSD-25) and schizophrenic reactions. A comparative study.
    Langs RJ; Barr HL
    J Nerv Ment Dis; 1968 Aug; 147(2):163-72. PubMed ID: 5677324
    [No Abstract]   [Full Text] [Related]  

  • 13. Differential behavioral responsivity to LSD-25, study in normal and schizophrenic adults.
    KRUS DM; WAPNER S; FREEMAN H; CASEY TM
    Arch Gen Psychiatry; 1963 Jun; 8():557-63. PubMed ID: 13927128
    [No Abstract]   [Full Text] [Related]  

  • 14. The influence of varying dosage on the effects of lysergic acid diethylamide (LSD-25) in humans.
    KLEE GD; BERTINO J; WEINTRAUB W; CALLAWAY E
    J Nerv Ment Dis; 1961 May; 132():404-9. PubMed ID: 13756607
    [No Abstract]   [Full Text] [Related]  

  • 15. [D-Lysergic acid diethylamide (LSD). 2. Clinical aspects].
    GROF S; VOJTECHOVSKY M; VOTAVA Z
    Lek Veda Zahr; 1960; 11():245-51 contd. PubMed ID: 13858660
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of lysergic acid diethylamide (LSD-25) on impulse control.
    ARONSON H; KLEE GD
    J Nerv Ment Dis; 1960 Dec; 131():536-9. PubMed ID: 13684462
    [No Abstract]   [Full Text] [Related]  

  • 17. Pupil dilatation in normal and schizophrenic subjects following lysergic acid diethylamide ingestion.
    FREEMAN H
    AMA Arch Neurol Psychiatry; 1958 Mar; 79(3):341-4. PubMed ID: 13507765
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of D-lysergic acid diethylamide (LSD-25) on learning and retention.
    ARONSON H; WATERMANN CE; KLEE GD
    J Clin Exp Psychopathol Q Rev Psychiatry Neurol; 1962; 23():17-23. PubMed ID: 13862516
    [No Abstract]   [Full Text] [Related]  

  • 19. Autistic schizophrenic children. An experiment in the use of d-lysergic acid diethylamide (LSD-25).
    FREEDMAN AM; EBIN EV; WILSON EA
    Arch Gen Psychiatry; 1962 Mar; 6():203-13. PubMed ID: 13894863
    [No Abstract]   [Full Text] [Related]  

  • 20. What is schizophrenia?
    Zubin J; Ludwig AM
    Schizophr Bull; 1983; 9(3):331-5. PubMed ID: 6622992
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.